Company data
Corcept Therapeutics Incorporated employees and revenue per employee
CORT · Medical - Pharmaceuticals · $12.6B market cap
Corcept Therapeutics Incorporated had 730 employees at the end of fiscal Dec 2025, up 46.0% from a year earlier. Revenue for the year was $761M, up 12.8% from a year earlier, or $1.04M per employee. Headcount grew faster than revenue.
Employees
730
+46.0% YoY
Revenue
$761M
+12.8% YoY
Revenue / employee
$1.04M
Peer median $464K
Rank in sector
34 of 135
Healthcare
Open roles
78
107 per 1,000 staff
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 730 | $761M | $1.04M | +46.0% | +12.8% |
| Dec 2024 | 500 | $675M | $1.35M | +42.0% | +39.9% |
| Dec 2023 | 352 | $482M | $1.37M | +17.7% | +20.0% |
| Dec 2022 | 299 | $402M | $1.34M | +25.6% | +9.8% |
| Dec 2021 | 238 | $366M | $1.54M | +0.8% | +3.4% |
| Dec 2020 | 236 | $354M | $1.50M | +14.6% | +15.5% |
| Dec 2019 | 206 | $306M | $1.49M | +24.1% | +22.0% |
| Dec 2018 | 166 | $251M | $1.51M | +22.1% | +57.8% |
| Dec 2017 | 136 | $159M | $1.17M | +32.0% | +95.8% |
| Dec 2016 | 103 | $81.3M | $790K | — | — |
Open roles on its job board: 78 (107 per 1,000 staff, against its latest annual headcount), as of 2026-10-07. Tracked since 2026-10-03. No 90 day change yet.
Corcept Therapeutics Incorporated against similar companies
The closest sector peers by revenue, from Healthcare.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. | 435 | $875M | $2.01M | Leaner |
| TGTX TG Therapeutics, Inc. | 399 | $616M | $1.54M | Efficient growth |
| ARWR Arrowhead Pharmaceuticals, Inc. | 711 | $829M | $1.17M | Efficient growth |
| CORT Corcept Therapeutics Incorporated | 730 | $761M | $1.04M | Hiring ahead |
| DOCS Doximity, Inc. | 880 | $645M | $733K | Efficient growth |
| AXSM Axsome Therapeutics, Inc. | 925 | $638M | $690K | Efficient growth |
| TXG 10x Genomics, Inc. | 1,178 | $643M | $546K | Leaner |
| RGEN Repligen Corporation | 2,000 | $738M | $369K | Efficient growth |
| NEOG Neogen Corporation | 2,636 | $870M | $330K | Contracting |
Questions about Corcept Therapeutics Incorporated
- How many employees does Corcept Therapeutics Incorporated have?
- Corcept Therapeutics Incorporated reported 730 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 24, 2026. That is up 46.0% from a year earlier.
- What is Corcept Therapeutics Incorporated's revenue per employee?
- Corcept Therapeutics Incorporated brought in $761M of revenue in fiscal Dec 2025, which is $1.04M per employee. That ranks 34 of 135 companies we track in Healthcare, where the median is $464K.
- Is Corcept Therapeutics Incorporated hiring?
- Corcept Therapeutics Incorporated's public job board listed 78 open roles on October 7, 2026, about 107 per 1,000 staff.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare CORT with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Corcept Therapeutics Incorporated's annual reports (Form 10-K), latest filed February 24, 2026. This is data, not a recommendation to buy or sell CORT.